Literature DB >> 27499257

Dermatitis herpetiformis: a cutaneous manifestation of coeliac disease.

Pekka Collin1, Teea T Salmi2,3, Kaisa Hervonen2,3, Katri Kaukinen3,4, Timo Reunala2,3.   

Abstract

Dermatitis herpetiformis (DH) is an itchy blistering skin disease with predilection sites on elbows, knees, and buttocks. Diagnosis is confirmed by showing granular immunoglobulin A deposits in perilesional skin. DH is one manifestation of coeliac disease; the skin symptoms heal with gluten free diet (GFD) and relapse on gluten challenge. Of the first-degree relatives, 5% may be affected by either condition. Tissue transglutaminase (TG2) is the autoantigen in coeliac disease and epidermal transglutaminase (TG3) in DH. Both diseases conditions exhibit TG2-specific autoantibodies in serum and small bowel mucosa; patients with DH have IgA-TG3 in the skin. There are some divergencies between these two phenotypes. One-fourth of DH patients do not have small bowel mucosal villous atrophy, but virtually all have coeliac-type inflammatory changes. The skin symptoms respond slowly to GFD. The incidence of coeliac disease is increasing, whereas the opposite is true for DH. A female predominance is evident in coeliac disease, while DH may be more common in males. Coeliac disease carries the risk of small intestinal T-cell lymphoma; in DH B-cell lymphomas at any site may prevail. Adult coeliac disease carries a slightly increased elevated mortality risk, whereas in DH, the relative mortality rate is significantly decreased. Key messages Dermatitis herpetiformis is a cutaneous manifestation of coeliac disease; both conditions are genetically determined and gluten-dependent. Gastrointestinal symptoms and the degree of villous atrophy are less obvious in dermatitis herpetiformis than in coeliac disease. Both show tissue transglutaminase (TG2) specific autoantibodies in serum and small bowel mucosa. In addition, TG3-targeted IgA antibodies are found in the skin of DH patients Both conditions carry an increased elevated risk of lymphoma, in coeliac disease small intestinal T-cell lymphoma, in dermatitis herpetiformis mainly B-cell lymphoma at various sites. Coeliac disease is currently eight times more common that DH; the incidence of DH is decreasing in contrast to that of coeliac disease, where it is increasing.

Entities:  

Keywords:  Bullous dermatoses; coeliac disease; dermatitis herpetiformis; gluten intolerance; tissue transglutaminase

Mesh:

Substances:

Year:  2016        PMID: 27499257     DOI: 10.1080/07853890.2016.1222450

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  20 in total

Review 1.  A Comprehensive Review of Celiac Disease/Gluten-Sensitive Enteropathies.

Authors:  Brian P McAllister; Emmanuelle Williams; Kofi Clarke
Journal:  Clin Rev Allergy Immunol       Date:  2019-10       Impact factor: 8.667

Review 2.  Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease.

Authors:  Stefania Martucciello; Gaetana Paolella; Carla Esposito; Marilena Lepretti; Ivana Caputo
Journal:  Cell Mol Life Sci       Date:  2018-08-22       Impact factor: 9.261

3.  Prevalence of Dermatitis Herpetiformis Within the iCureCeliac Patient-Powered Research Network-Patient Characteristics and Dietary Counseling.

Authors:  Bridget E Shields; Joel M Gelfand; Lynne Allen-Taylor; Misha Rosenbach
Journal:  JAMA Dermatol       Date:  2020-12-01       Impact factor: 10.282

4.  Granular Deposits of IgA in the Skin of Coeliac Patients Without Dermatitis Herpetiformis: A Prospective Multicentric Analysis.

Authors:  Emiliano Antiga; Roberto Maglie; Gabriele Lami; Alessandro Tozzi; Veronica Bonciolini; Francesca Calella; Beatrice Bianchi; Elena Del Bianco; Daniela Renzi; Edoardo Mazzarese; Antonino S Calabrò; Marzia Caproni
Journal:  Acta Derm Venereol       Date:  2021-02-02       Impact factor: 3.875

Review 5.  Current Concepts of Dermatitis Herpetiformis.

Authors:  Teea Salmi; Kaisa Hervonen
Journal:  Acta Derm Venereol       Date:  2020-02-12       Impact factor: 3.875

Review 6.  Extra-intestinal manifestations of non-celiac gluten sensitivity: An expanding paradigm.

Authors:  Giuseppe Losurdo; Mariabeatrice Principi; Andrea Iannone; Annacinzia Amoruso; Enzo Ierardi; Alfredo Di Leo; Michele Barone
Journal:  World J Gastroenterol       Date:  2018-04-14       Impact factor: 5.742

7.  Self-Reported Fractures in Dermatitis Herpetiformis Compared to Coeliac Disease.

Authors:  Camilla Pasternack; Eriika Mansikka; Katri Kaukinen; Kaisa Hervonen; Timo Reunala; Pekka Collin; Heini Huhtala; Ville M Mattila; Teea Salmi
Journal:  Nutrients       Date:  2018-03-14       Impact factor: 5.717

8.  Prognosis of Dermatitis Herpetiformis Patients with and without Villous Atrophy at Diagnosis.

Authors:  Eriika Mansikka; Kaisa Hervonen; Katri Kaukinen; Pekka Collin; Heini Huhtala; Timo Reunala; Teea Salmi
Journal:  Nutrients       Date:  2018-05-19       Impact factor: 5.717

Review 9.  Interplay between Type 2 Transglutaminase (TG2), Gliadin Peptide 31-43 and Anti-TG2 Antibodies in Celiac Disease.

Authors:  Stefania Martucciello; Silvia Sposito; Carla Esposito; Gaetana Paolella; Ivana Caputo
Journal:  Int J Mol Sci       Date:  2020-05-23       Impact factor: 5.923

Review 10.  Coeliac Disease Pathogenesis: The Uncertainties of a Well-Known Immune Mediated Disorder.

Authors:  Margaret R Dunne; Greg Byrne; Fernando G Chirdo; Conleth Feighery
Journal:  Front Immunol       Date:  2020-07-08       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.